Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 79.50 trillion as of October 17, 2025. Its market cap has increased by 15.04% in one year.

Market Cap

79.50T

Enterprise Value

79.27T

Revenue

5.03T

Ranking

n/a

PE Ratio

61.83

Stock Price

1,117,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 79.50T, an increase of 734.42%. That is a compound annual growth rate of 26.78%.

Market Cap History

Date	Market Cap	% Change
Oct 17, 2025	79.50T	17.70%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	54.65T	90.76%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Nov 10, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	38.55T
ALTEOGEN	23.16T
Yuhan	8,731.52B
SK Biopharmaceuticals	8,050.60B
Peptron	5,980.90B
PharmaResearch	5,849.37B
HLB Co., Ltd.	5,221.68B
LigaChem Biosciences	4,791.80B

Market Cap Rankings